Ophthalmology Times Staff Reports

Articles

Researchers seeking fluid features, retinal integrity measures to test next step in image analysis and image interrogation in clinical trials.

ASRS 2019 Street Team: Justis P. Ehlers, MD

David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.

ASRS 2019 Street Team: David S. Boyer, MD

Results from TIME-2, a phase IIA study, support further development of combination treatment with subcutaneous injection of the Tie2 activator, AKB-9778 (Aerpio Therapeutics), plus intravitreous (IVT) anti-VEGF injection for diabetic macular edema.

Author | Ophthalmology Times Staff Reports

Articles

New content coming soon, please check back later.